Regulation of liver regeneration

Nephrology Dialysis Transplantation

Volumn 19, Issue SUPPL. 4, 2004, Pages

  Zimmermann, Arthur ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Hepatocyte proliferation; Hepatocyte regeneration; Initiation; Liver regeneration; Regeneration regulation; Termination

Indexed keywords

ACTIVIN; CYTOKINE; INTERLEUKIN 6; SCATTER FACTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENETIC REGULATION; HUMAN; IMMUNOREGULATION; INNER CELL MASS; KUPFFER CELL; LIVER CELL; LIVER CIRCULATION; LIVER REGENERATION; LIVER RESECTION; LIVER SINUSOID; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CYCLIN-DEPENDENT KINASES; CYTOKINES; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; INTERLEUKIN-6; LIVER REGENERATION; RATS; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4344624078     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1034     Document Type: Article

References (23)

1. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-66
2. Streetz KL, Luedde T, Manns MP, Trautwein C. Interleukin 6 and liver regeneration. Gut 2000; 47: 309-312
3. Denson LA, Held MA, Menon RK, Frank SJ, Parlow AF, Arnold DL. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol 2003; 284: G646-G654
4. Wuestefeld T, Klein C, Streetz KL et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003; 278: 11281-11288
5. Anderson SP, Yoon L, Richard EB, Dunn CS, Cattley RC, Corton JC. Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. Hepatology 2002; 36: 544-554
6. Hattori T, Ohoka N, Hayashi H, Onozaki K. C/EBP homologous protein (CHOP) up-regulates IL-6 transcription by trapping negative regulating NF-IL6 isoform. FEBS Lett 2003; 541: 33-39
7. Leclercq IA, Field J, Farrell GC. Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 2003; 124: 1451-1464
8. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 1996; 10: 413-427
9. Leu JI, Crissey MA, Craig LE, Taub R. Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1 - deficient mice with defects in C/EBPbeta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 2003; 23: 1251-1259
10. Naganuma S, Itoh H, Uchiyama S et al. Characterization of transcripts generated from mouse hepatocyte growth factor activator inhibitor type 2 ( HAI-2 ) and HAI-2-related small peptide ( H2RSP ) genes: chimeric mRNA transcribed from both HAI-2 and H2RSP genes is detected in human but not in mouse. Biochem Biophys Res Commun 2003; 302: 345-353
11. Liu H, Di Cunto F, Imarisio S, Reid LM. Citron kinase is a cell cycle-dependent, nuclear protein required for G2/M transition of hepatocytes. J Biol Chem 2003; 278: 2541-2548
12. Garcia-Ruiz C, Colell A, Mari M et al. Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 2003; 111: 197-208
13. Ku NO, Soetikno RM, Omary MB. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. Hepatology 2003; 37: 1006-1014
14. Nakamura T, Sakata R, Ueno T et al. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000; 32: 247-255
15. Villevalois-Cam L, Rescan C, Gilot D et al. The hepatocyte is a direct target for transforming-growth factor beta activation via the insulin-like growth factor II/mannose 6-phosphate receptor. J Hepatol 2003; 38: 156-163
16. Date M, Matsuzaki K, Matsushita M et al. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J Hepatol 2000; 32: 251-260
17. Macias-Silva M, Li W, Leu JI, Crissey MA, Taub R. Upregulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. J Biol Chem 2002; 277: 28483-28490
18. LeCouter J, Moritz DR, Li B et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003; 299: 890-893
19. Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ. Activated stellate cells express TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003; 37: 87-95
20. Kalininchenko VV, Bhattacharyya D, Zhou Y et al. Foxfl +/-mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology 2003; 37: 107-117
21. Issa R, Zhou X, Trim N et al. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells and diminished hepatocyte regeneration. FASEB J 2003; 17: 47-49
22. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores G.J. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 2003; 83: 655-663
23. Zimmermann A, Gloor B, Kappeler A, Uhl W, Friess H, Büchler MW. Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans. Gut 2002; 51: 574-578